Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Goodwill & Intangibles came in at $240.2 million in Q1 2026, up 63.05% YoY from $147.3 million in Q1 2025, and little changed on a QoQ basis from $240.2 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Goodwill & Intangibles (2022 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 5 years of Goodwill & Intangibles data on file, last reported at $240.2 million in Q1 2026.
- Quarterly Goodwill & Intangibles rose 63.05% year-over-year to $240.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $240.2 million (up 63.05% YoY) and the FY2025 annual result came in at $240.2 million, up 53.32% from the prior year.
- Goodwill & Intangibles held at $240.2 million in Q1 2026, from $240.2 million in the prior quarter.
- In the past five years, Goodwill & Intangibles ranged from a high of $240.2 million in Q4 2025 to a low of $32.5 million in Q4 2022.
- A 5-year average of $166.4 million and a median of $175.4 million in 2024 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles jumped 601.28% — and 2024, when it plunged 31.2%.
- Tracing CPRX's Goodwill & Intangibles over 5 years: stood at $32.5 million in 2022, then jumped by 601.28% to $227.7 million in 2023, then slumped by 31.2% to $156.7 million in 2024, then surged by 53.32% to $240.2 million in 2025, then changed by 0.0% to $240.2 million in 2026.
- The last three Goodwill & Intangibles figures came in at $240.2 million (Q1 2026), $240.2 million (Q4 2025), and $227.7 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 240.21 Mn |
| Dec 31, 2025 | 240.21 Mn |
| Sep 30, 2025 | 227.71 Mn |
| Jun 30, 2025 | 137.98 Mn |
| Mar 31, 2025 | 147.33 Mn |
| Dec 31, 2024 | 156.67 Mn |
| Sep 30, 2024 | 166.02 Mn |
| Jun 30, 2024 | 175.36 Mn |
| Mar 31, 2024 | 184.71 Mn |
| Dec 31, 2023 | 227.71 Mn |
| Sep 30, 2023 | 167.11 Mn |
| Jun 30, 2023 | 175.60 Mn |
| Mar 31, 2023 | 184.08 Mn |
| Dec 31, 2022 | 32.47 Mn |
| Sep 30, 2022 | 33.05 Mn |